HILAX
Price
$28.45
Change
+$0.29 (+1.03%)
Updated
Aug 21 closing price
Net Assets
16.52B
VIHAX
Price
$50.90
Change
+$0.55 (+1.09%)
Updated
Aug 21 closing price
Net Assets
21.87B
Interact to see
Advertisement

HILAX vs VIHAX

HILAX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
HILAX vs. VIHAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HILAX is a StrongBuy and VIHAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 21.9B vs. HILAX (16.5B). VIHAX pays higher dividends than HILAX: VIHAX (3.45) vs HILAX (2.49). HILAX was incepted earlier than VIHAX: HILAX (16 years) vs VIHAX (10 years). HILAX (1.18) is less costly to investors than VIHAX (0.16). HILAX is a more actively managed with annual turnover of: 19.00 vs. VIHAX (9.00). HILAX has a lower initial minimum investment than VIHAX: HILAX (2000) vs VIHAX (3000). VIHAX annual gain was more profitable for investors over the last year : 25.96 vs. HILAX (24.51). HILAX return over 5 years is better than : 106.92 vs. VIHAX (66.41).
HILAXVIHAXHILAX / VIHAX
Total Expense Ratio1.180.16737%
Annual Report Gross Expense Ratio1.180.16737%
Fund Existence16 years10 years-
Gain YTD18.64117.601106%
Front Load6%N/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets16.5B21.9B75%
Annual Yield % from dividends2.493.4572%
Returns for 1 year24.5125.9694%
Returns for 3 years85.6975.63113%
Returns for 5 years106.9266.41161%
Returns for 10 years144.10108.07133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMOCX19.250.23
+1.21%
Victory RS Mid Cap Growth C
CIVHX22.290.17
+0.77%
American Funds Intl Vntg 529-F-3
GSYPX45.930.22
+0.48%
Goldman Sachs Small Cap Value P
PASTX68.290.18
+0.26%
T. Rowe Price Science & Tech Adv
JMNCX12.25-0.01
-0.08%
JPMorgan Research Market Neutral C